643 related articles for article (PubMed ID: 17513028)
1. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
[TBL] [Abstract][Full Text] [Related]
3. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
[TBL] [Abstract][Full Text] [Related]
5. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
Naidu PS; Singh A; Kulkarni SK
Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
[TBL] [Abstract][Full Text] [Related]
7. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2009 Jan; 91(3):423-9. PubMed ID: 18789960
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacology; 2007; 79(3):171-83. PubMed ID: 17377417
[TBL] [Abstract][Full Text] [Related]
10. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Bishnoi M; Kumar A; Chopra K; Kulkarni SK
Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
[TBL] [Abstract][Full Text] [Related]
11. Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.
Singh A; Naidu PS; Kulkarni SK
Eur J Pharmacol; 2003 Sep; 477(2):87-94. PubMed ID: 14519411
[TBL] [Abstract][Full Text] [Related]
12. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation.
Datta S; Jamwal S; Deshmukh R; Kumar P
Eur J Pharmacol; 2016 Jan; 771():229-35. PubMed ID: 26712377
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
Naidu PS; Singh A; Kulkarni SK
Br J Pharmacol; 2002 May; 136(2):193-200. PubMed ID: 12010767
[TBL] [Abstract][Full Text] [Related]
15. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
Naidu PS; Singh A; Kulkarni SK
Pharmacology; 2004 Feb; 70(2):59-67. PubMed ID: 14685008
[TBL] [Abstract][Full Text] [Related]
16. Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats.
Sanghavi CR; Barhate SA; Mahajan MS; Mohan M; Kasture SB
Nat Prod Res; 2011 Apr; 25(7):704-15. PubMed ID: 20628966
[TBL] [Abstract][Full Text] [Related]
17. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
Burger ME; Fachinetto R; Zeni G; Rocha JB
Pharmacol Biochem Behav; 2005 Jul; 81(3):608-15. PubMed ID: 15953628
[TBL] [Abstract][Full Text] [Related]
18. B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.
Macêdo DS; Oliveira GV; Gomes PX; Araújo FY; Souza CM; Vasconcelos SM; Viana GS; Sousa FC; Carvalho AF
Behav Pharmacol; 2011 Oct; 22(7):674-80. PubMed ID: 21918383
[TBL] [Abstract][Full Text] [Related]
19. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
Naidu PS; Singh A; Kulkarni SK
Neuropharmacology; 2003 Jun; 44(8):1100-6. PubMed ID: 12763102
[TBL] [Abstract][Full Text] [Related]
20. Reversal of haloperidol-induced orofacial dyskinesia by Murraya koenigii leaves in experimental animals.
Patil R; Hiray Y; Shinde S; Langade P
Pharm Biol; 2012 Jun; 50(6):691-7. PubMed ID: 22136413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
